Antibody Detection & Identification Flashcards
When to suspect an antibody?
ABO discrepancy pos Ab screen incompatible crossmatch transfusion reaction pos DAT HDFNB
screening cells must have what antigens on them
D,C,c,E,e,M,N,S,s,Lea,Leb,Pi,K,k,Fya, fyb, jka, jkb
3 cell screening kits must include what antigens?
homozygous Duffy & Kidd antigens
R1R1, R2R2 & rr cells must all be included
expiration time frame for all red cell reagents
every 3 weeks
BB labs have standing orders
antibody screen limitations
may miss:
low titered antibodies (Kidd)
Ab to low frequency antigens
Ab that do not react under the experimental conditions (pH, LISS, other ions etc)
BSA
bovine serum albumin in either 22% or 30%
mechanism is unclear
enhances the sensitivity at AHG phase for most antibodies
requires an increased incubation time!
LISS
low ionic strength solution: increases the rate of Ab binding to specific Ag sites on the RBC by decreasing zeta potential
equal volumes of serum & LISS!
limitations of LISS
enhances cold autoantibodies & may miss weak Kell Ab
PEG
polyethylene glycol: removes water molecules to allow greater chance for collision between antigen & Ab
DO NOT CENTRIFUGE until saline has been added
Proteolytic enzymes
papin, ficin, & bromelin
causes breakdown of protein molecules
enhance: Rh, Kidd, Lewis, I, P Ab
denatures: M,N, Fya, Fyb
Enhanced methods
ortho gel or immucor capture systems enhanced sensitivity automated objective cost pulls up non-clinicially-relevant Ab
laboratory information systems
built in systems/checks in place to prevent mistyping, missing antibodies, & other clinically relevant information
always need to confirm all the information on a patient’s file
DAT detects:
Ab that have been formed IN VIVO:
autoantibodies
alloantibodies following transfusion
DAT reagent
polyspecific AHG for IgG & C3d
if positive, one can go back and test with separate reagents to determine if antibody mediated or complement mediated
possible reasons why all 3 cells in a DAT would have various reaction strengths
dosage
multiple antibodies
multiple specificity